Is a master protocol accepted by FDA, or is it just an efficiency tool for sponsors?

FDA formally supports master protocols and has published guidance, including agency guidance on master protocols for oncology drug and biologic development, describing how sponsors should address statistical multiplicity, control-arm sharing, and interim decision rules when using this design. For device evidence generation, master protocols are increasingly used for companion diagnostic studies and multi-arm imaging or AI model evaluations, though sponsors should engage FDA early through the Q-Submission process since the statistical and operational complexity raises review questions not present in single-arm or single-indication trials.

What operational challenges are unique to master protocols?

Master protocols require governance structures, such as an independent data monitoring committee empowered to add or drop sub-studies, standardized case report forms across sub-studies, and statistical analysis plans that pre-specify how type I error is controlled when interventions or arms are added mid-trial. Sites and IRBs must also be prepared to review protocol amendments that add or remove arms without re-consenting the entire trial population, which requires careful informed consent and IRB communication planning from the outset.

What is a common mistake sponsors make when adopting a master protocol?

A common mistake is underestimating the statistical complexity of shared control arms and multiplicity control when new sub-studies are added later, which can undermine the interpretability of comparisons if not pre-specified. Sponsors should finalize the statistical analysis plan's rules for arm addition, interim analyses, and error-rate control before enrollment begins, and should not treat a master protocol as simply a bundle of independent studies sharing paperwork.

All terms

Clinical & TrialsClinical Evidence

Master Protocol (Basket / Umbrella / Platform)

A single protocol that evaluates multiple interventions, populations, or sub-studies under a unified statistical and operational framework.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

Definition

A master protocol is a single overarching trial protocol that simultaneously evaluates multiple interventions or populations: basket trials test one therapy across multiple diseases sharing a common biomarker; umbrella trials test multiple therapies in a single disease stratified by biomarker; platform trials evaluate multiple therapies against a common control with sub-studies that can drop or add over time. The architecture reduces administrative overhead, shares control arms, and accelerates evidence generation.

What the regulation says

FDA Guidance: 'Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics' (March 2022). NIH and the FDA-NIH Joint Leadership Council have published companion playbooks.

What this means in practice

Master protocols originated in oncology and have spread to neurology, infectious disease, and increasingly device evidence generation (companion diagnostic studies, multi-arm imaging AI evaluations).

Examples

A basket trial master protocol might investigate the efficacy of a new targeted therapy in patients with various types of solid tumors, all sharing a specific genetic mutation identified through a common biomarker.
An umbrella trial master protocol could evaluate several investigational therapies for a particular neurological disease, assigning patients to different treatment arms based on their unique biomarker profiles within that single disease.
A platform trial master protocol for an infectious disease might continuously evaluate multiple new antiviral compounds against a shared control arm, allowing less effective treatments to be dropped and new promising ones to be added over time without restarting the entire study.

Common pitfalls

•Underestimating the operational complexity, master protocols simplify design and complicate execution.
•Failing to define add/drop rules and DSMB authority precisely up front.

Frequently asked questions

A basket trial tests one intervention across multiple diseases or device indications that share a common biomarker or mechanism, an umbrella trial tests multiple interventions within a single disease population stratified by biomarker, and a platform trial evaluates multiple interventions against a shared control arm with sub-studies that can be added or dropped over time as evidence accumulates. All three share a single overarching master protocol, common infrastructure, and often a shared statistical framework, which distinguishes them from running each sub-study as an independent trial.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Clinical & Trials

Adaptive Trial Design

Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.

Clinical & Trials

Bayesian Trial Design

Trial design that uses Bayesian statistics, often incorporating prior data from related studies or registries.

Clinical & Trials

Data Safety Monitoring Board(DSMB)

Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial.

Clinical & Trials

Pivotal Trial

Definitive clinical study designed to establish safety and effectiveness for marketing authorization.

Latest in MedTech

Sources

3 sources

Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 2Tier 3Peer-reviewed and registry evidence· 1

Link health: 3 verified· last checked 2026-06-20

FDA·2NIH·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Clinical & Trials0 / 52

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Clinical & Trials
Sources: 3
Updated: 5/9/2026

Compare with another term

Learn in 60 seconds

A single protocol that evaluates multiple interventions, populations, or sub-studies under a unified statistical and operational framework.

·Master protocols originated in oncology and have spread to neurology, infectious disease, and increasingly device evidence generation (companion diagnostic studies, multi-arm imaging AI evaluations).
·The architecture reduces administrative overhead, shares control arms, and accelerates evidence generation.

Remember this

Watch out: Underestimating the operational complexity, master protocols simplify design and complicate execution.

Related terms

You may also need

Auto-suggested from Clinical & Trials and shared keywords.

All Clinical & Trials terms

From the Blue Goat network

Related resources and services on this topic.

MedTech Launchpad
MedTech funding rounds, accelerators, and launch resources.

Definition

What this means in practice

Examples

Frequently asked questions

Related terms

Editor's picks

More in Clinical & Trials

Latest in MedTech

Sources